Home Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
Article
Licensed
Unlicensed Requires Authentication

Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection

  • Margareta Nyman , Lottie Skjöldebrand-Sparre and Kristina Broliden
Published/Copyright: March 1, 2005
Journal of Perinatal Medicine
From the journal Volume 33 Issue 2

Abstract

Aims: Clinical follow-up of possible fetal complications associated with maternal parvovirus B19 infection is usually recommended during the 2–3 months after primary infection.

Results: A case of late intrauterine fetal death associated with at least 5 months of maternal parvovirus B19 viremia and in the presence of B19 IgG and IgM is described.

Conclusions: The time of clinical and laboratory follow-up after maternal parvovirus B19 infection may need to be revised if prolonged viremia is more common than previously described.

:

Corresponding author: Kristina Broliden, Infectious Diseases Unit, F68, Karolinska Institutet, Karolinska University Hospital, Solna SE-17177 Stockholm/Sweden. Tel.: +46-8-51770000; Fax +46-8-337394;

References

1 Corcoran A, BP Mahon, P McParland, A Davoren, S Doyle: Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol70 (2003) 475Search in Google Scholar

2 Jordan JA, D Huff, JA DeLoia: Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immmunol8 (2001) 288Search in Google Scholar

3 Koch WC, JH Harger, B Barnstein B, SP Adler: Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J17 (1998) 489Search in Google Scholar

4 Miller E, CK Fairley, BJ Cohen, C Seng: Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol105 (1998) 174Search in Google Scholar

5 Nonoue T, K Kusuhara, T Hara: Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J21 (2002) 1133Search in Google Scholar

6 O'Malley A, C Barry-Kinsella, C Hughes, P Kelehan, D Devaney, E Mooney, J Gillan: Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol6 (2003) 414Search in Google Scholar

7 Skjoldebrand L, T Tolfvenstam, N Papadogiannakis, B Wahren, K Broliden, M Nyman: Parvovirus B19 infection: association with third-trimester intrauterine fetal death. Br J Obstet Gynaecol107 (2000) 476Search in Google Scholar

8 Söderlund M, R von Essen, J Haapasaari, U Kiistala, O Kiviluoto, K Hedman: Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet349 (1997) 1063Search in Google Scholar

9 Tolfvenstam T, N Papadogiannakis, O Norbeck, K Petersson, K Broliden: Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet357 (2001) 1494Search in Google Scholar

Published Online: 2005-03-01
Published in Print: 2005-03-01

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Declining fertility in the developed world and high maternal mortality in developing countries – how do we respond?
  2. Maternal obesity and complications during pregnancy
  3. Cesarean section upon request: is it appropriate for everybody?
  4. Reply to: Cesarean section upon request: is it appropriate for everybody?
  5. Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets
  6. Gestational age-specific distribution of twin birth weight discordance
  7. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy
  8. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®)
  9. Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes
  10. Is cervical dilatation during parturition at term associated with apoptosis?
  11. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
  12. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
  13. Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update
  14. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants
  15. Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections
  16. Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants
  17. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
  18. A new syndrome of myopathy with muscle spindle excess*
  19. Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother
Downloaded on 1.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2005.033/pdf
Scroll to top button